ClinicalTrials.gg
RecruitingNCT06396546I-GSDUpdated Aug 5, 2026

'Glycogen Storage Diseases (GSDs) in Indian Children- Establishing an Indian GSD (I-GSD) Registry'

An observational study in Glycogen Storage Diseases, sponsored by Institute of Liver and Biliary Sciences, India. Recruiting at 37 sites in India. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2026-08-05.

Sponsored by Institute of Liver and Biliary Sciences, India · Observational

From the registry’s dates

  • Started May 2024; still recruiting 2 years 6 months later.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
250
Ages
Up to 18 Years
Sex
All
01

Study summary

Glycogen storage disorders (GSD) are a class of inborn metabolic abnormalities characterized by enzymatic defects in glycogen production or breakdown and are one of commonest metabolic disorders of the childhood. Their pathogenesis mostly involves the liver and muscles and can range in severity from minor disorders with a typical lifespan to those that are fatal in infancy. Different GSDs, such as type 0a, I, III (most common type), IV, VI, IX, and XI (based on specific gene variants) are now referred to as hepatic GSDs involving liver (+ muscle). GSDs show clinically in a wide range of ways, and they have typically been identified by combining clinical symptoms, biochemical data, and pathological findings. But due to lack of multicentre evaluation, there is persistent scarcity of data with regard to the overall spectrum of genetic defects in Indian children presenting with GSD, their natural course and genotype-phenotype correlation. Also, there is limited data on common genetic variations in Indian population causing hepatic glycogen storage diseases.

An Indian GSD registry is needed to describe the spectrum, natural course, genotype-phenotype correlation, outcome and response to medical therapy in Indian children with GSDs. The study would be the first to extensively describe the genotype of Indian children with GSD and their natural course. Being a multicentric study, the results generated would therefore be applicable to the whole of the country. Understanding the prevalent genotypes in Indian population and their related phenotype would help both the individual management decisions of these patients and further policy making for their diagnosis and treatment. Results from this study could thus guide appropriate decision making based on outcome and help choose the modality of treatment for the individual patient - medical, or liver transplantation.

Read the detailed description
  • Primary objective:
  • To describe the clinical presentation and outcome of genetically defined cases of pediatric hepatic glycogen storage diseases (GSD) patients.
  • Study population: Genetically confirmed cases of hepatic GSDs will be enrolled from all the participating centres.
  • Study design: Multicentric retrospective study (with concomitant long term prospective data collection)
  • Study period: The study will be an ongoing effort with aim to continuosly expand the participation. Retrospective data collection (of previous data), analysis and drafting of manuscript would be completed between May 2024 to April 2025. New centers willing to join the consortium will be asked to submit their data as on the date of joining. Retrospective follow up data may be asked from the participating centres every every 6 months-1 year. Also, we would continue prospective data collection of newer GSD patients at the collaborating centres.
02

Conditions studied

  • Glycogen Storage Diseases
03

In context

Glycogen Storage Disease

36 studies on the registry are indexed under Glycogen Storage Disease; 13 are open to participants now.

This study's planned enrollment of 250 is above the median of 85 across 16 observational studies indexed under Glycogen Storage Disease.

Browse Glycogen Storage Disease studies →

Lead sponsor

Institute of Liver and Biliary Sciences, India is the lead sponsor of 302 studies on the registry; 87 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Genetically confirmed cases of hepatic GSDs will be enrolled from all the participating centres.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children \<18 years of age (at presentation) with genetically proven (homozygous or compound heterozygous mutations) hepatic glycogen storage diseases

    1. types 0a/GYS2 gene, I/G6PC or SLC37A4 gene variants, III/ AGL gene variants, IV/ GBE1 gene variants, VI/ PYGL gene variants, IX/ PHKA2, PHKB or PHKG2 gene variants and XI/ GLUT2/SLC2A2 gene variants.

Exclusion criteria

Exclusion Criteria:

-

  • Clinical, biochemical and histological evidence of GSDs without a confirmatory genetic sequencing report.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
250 participants (estimated)
Target follow-up
10 Years
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Evaluate clinical presentation and outcome (long term native liver or post liver transplant survival etc) of genetically defined cases of Indian pediatric hepatic glycogen storage diseases (GSD) patients.

    Clinical presentation defined as symptomatology, biochemical and genetic features etc.

    Time frame: 5 years

Secondary outcomes

  1. Various types of genetic variations (missense, nonsense, frameshift etc) in Indian children with GSD.

    Time frame: Day 0

  2. Association between specific genetic variations (genotype) and the resulting clinical disease expression (phenotype) in Indian children with various types of hepatic GSDs.

    Time frame: 5 years

  3. To evaluate the complications and outcome after liver transplantation in Indian children with various types of hepatic GSDs.

    Time frame: 5 years

07

Study locations

37 of 37 sites recruiting
  • Rainbow children's hospital
    Guindy, Chennai 600015, India
    Recruiting
  • Gujarat Superspeciality Clinic
    Ahmedabad, Gujarat 380009, India
    Recruiting
  • Srijan Children Gastro & Liver Clinic
    Surat, Gujarat 395001, India
    Recruiting
  • Government medical college and its associated children hospital
    Srinagar, Jammu and Kashmir 190018, India
    Recruiting
  • Aster CMI Hospital
    Bengaluru, Karnataka 560092, India
    Recruiting
  • Mazumdar Shaw Medical Center
    Bengaluru, Karnataka 560099, India
    Recruiting
  • J. Hospital and Research Centre
    Mangalore, Karnataka 575004, India
    Recruiting
  • Lakeshore hospital and Research centre
    Kochi, Kerala 682040, India
    Recruiting
  • Government Medical College
    Thiruvananthapuram, Kerala 695011, India
    Recruiting
  • Gleneagles hospital
    Mumbai, Maharashtra 400012, India
    Recruiting
    • Dr Vibhor Borkar · Contact8828291707
  • All India Institute of Medical Sciences
    Nagpur, Maharashtra 441108, India
    Recruiting
  • KEM Hospital
    Pune, Maharashtra 411011, India
    Recruiting
  • Jupiter Hospital, Prathamesh Park
    Pune, Maharashtra 411045, India
    Recruiting
  • Jupiter Hospital
    Thane, Maharashtra, India
    Recruiting
  • Sir H N Reliance Foundation Hospital
    Girgaon, Mumbai 400004, India
    Recruiting
  • Institute of Liver & Biliary Sciences
    New Delhi, National Capital Territory of Delhi 110070, India
    Recruiting
  • Institute of Medical Sciences and SUM Hospital
    Bhubaneswar, Odisha 751003, India
    Recruiting
  • All India Institute of Medical Sceinces
    Bhubaneswar, Odisha 751019, India
    Recruiting
  • Kanchi Kamakoti CHILDS Trust Hospital
    Chennai, Tamil Nadu 600034, India
    Recruiting
  • Institute of Child Health & Hospital for Children
    Chennai, Tamil Nadu, India
    Recruiting
  • Dr RML institute of Medical Sciences
    Lucknow, U.P. 226010, India
    Recruiting
  • Artemis hospital
    Gurgaon, Uttar Pradesh 122001, India
    Recruiting
  • Prism Pediatricgastro
    Ahmedabad, 380008, India
    Recruiting
  • Apollo Children's Hospital
    Chennai, 600006, India
    Recruiting
  • Gleneagles Health City
    Chennai, 600119, India
    Recruiting
  • Ankura Hospital for Women and Children
    Hyderabad, 500018, India
    Recruiting
  • All India Institute of Medical Sciences
    Jhārkhand, 814152, India
    Recruiting
  • Regency Health Hospital
    Kanpur, 208005, India
    Recruiting
  • King George Medical University
    Lucknow, 226003, India
    Recruiting
  • Lokmanya Tilak Municipal Medical College and General Hospital
    Mumbai, 400022, India
    Recruiting
  • Jaslok Hospital and research Center
    Mumbai, 400026, India
    Recruiting
  • Max Hospital, Saket
    New Delhi, 110017, India
    Recruiting
  • Apollo Hospital
    New Delhi, 110076, India
    Recruiting
  • Child Gastro and Liver Care Centre
    Patna, 800020, India
    Recruiting
  • Jai Prabha Medanta Hospital
    Patna, 800020, India
    Recruiting
  • All India Institute of Medical Sciences
    Patna, 801507, India
    Recruiting
  • Ankura Hospital for women and children
    Vijayawada, 520010, India
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2024 (actual). Primary completion is estimated for Mar 2029, 58 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 13, 2024
First posted
May 2, 2024
StartActual
May 2, 2024
Primary completionEst.
Mar 31, 2029
CompletionEst.
Mar 31, 2029
Last update
Aug 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06396546
Responsible party
Vikrant Sood (Additional Professor,Pediatric hepatology, Institute of Liver and Biliary Sciences, India) — Principal investigator
First posted
May 2, 2024
Start date
May 2, 2024
Primary completion
Mar 31, 2029 (estimated)
Completion
Mar 31, 2029 (estimated)
Last update
Aug 5, 2026

Study contacts

Dr Vikrant Sood, DM
Contact
drvickyster@gmail.com
01146300000
Dr Vikrant Sood, DM
study director · Institute of Liver & Biliary Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion